rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
1998-11-5
|
pubmed:abstractText |
Lung dysfunction after transplantation continues to be a significant clinical problem. Soluble complement receptor 1 (sCR1) is a potent inhibitor of complement activation. We evaluated the inhibitory effect of sCR1 on complement activation and reperfusion injury in pig lung allografts.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0041-1337
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
27
|
pubmed:volume |
66
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
723-32
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9771835-Animals,
pubmed-meshheading:9771835-CHO Cells,
pubmed-meshheading:9771835-Complement C3b,
pubmed-meshheading:9771835-Complement Inactivator Proteins,
pubmed-meshheading:9771835-Cricetinae,
pubmed-meshheading:9771835-Fluorescent Antibody Technique,
pubmed-meshheading:9771835-Lung,
pubmed-meshheading:9771835-Lung Transplantation,
pubmed-meshheading:9771835-Oxygen,
pubmed-meshheading:9771835-Partial Pressure,
pubmed-meshheading:9771835-Random Allocation,
pubmed-meshheading:9771835-Receptors, Complement,
pubmed-meshheading:9771835-Swine
|
pubmed:year |
1998
|
pubmed:articleTitle |
Effect of complement inhibition with soluble complement receptor 1 on pig allotransplant lung function.
|
pubmed:affiliation |
Division of Thoracic Surgery, The Toronto Hospital, Ontario, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|